LillyObesityInt Profile Banner
Lilly Obesity International Profile
Lilly Obesity International

@LillyObesityInt

Followers
1K
Following
0
Media
166
Statuses
184

Channel for the Professional Obesity Community. Follow us for congress news, interviews & perspectives on obesity care. Guideline: https://t.co/M2mgEFJj4x

International
Joined May 2024
Don't wanna be here? Send us removal request.
@LillyObesityInt
Lilly Obesity International
30 days
Thank you for joining us at #EASD2025 – a week filled with science, discussion, and connection, where we had the opportunity to showcase our commitment to supporting the future of #Diabetes and #Cardiometabolic care.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
At Lilly, we believe progress happens when scientific advances make people’s lives better. A future where the science of interconnected #Cardiometabolic diseases is globally understood will help shift attitudes and make healthcare more accessible, connected, and human.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
Join Lilly and top experts on #EASD2025 TV as they delve into the role of #Obesity in daily clinical practice, examining its clinical relevance and biological complexity. Discover insights that support a more informed approach to care.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
Preventing #Cardiometabolic diseases starts with early detection and intervention.¹ Follow us for practical tools to support early detection and intervention.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
Stigma and bias can delay care and worsen outcomes for people with cardiometabolic conditions.¹⁻⁴ Lilly is working to reframe cardiometabolic conditions as complex, chronic diseases. Through science and innovation, we aim to challenge stigma and break down barriers to care.
0
0
20
@LillyObesityInt
Lilly Obesity International
1 month
To raise awareness of holistic Obesity care, our messages will be featured on posters across Vienna’s streets and subways during #EASD2025—look out for them across the city. For healthcare professionals at this year’s congress in Vienna, follow us for the latest.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
Experts Dr. Arya Sharma and Prof. Rachel Batterham will explore how we can shift from weight-centric care to a health-first, outcomes-based approach. If you are an HCP working in #Obesity, #Cardiometabolic care, or Diabetes make sure you don’t miss this educational session!
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
At Lilly, we are dedicated to improving people’s lives by deepening the understanding of #Cardiometabolic diseases and the connections between them. Follow us for more insights.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
While you’re at #EASD2025, look out for our Obesity awareness campaign across Vienna’s streets—spotlighting the importance of holistic care. Attending EASD 2025 as a healthcare professional? Follow along for updates.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
Guidelines across cardiometabolic care are clear: early intervention is critical.¹⁻³ Early, intensive combination intervention can prevent disease progression and events in those living with #Cardiometabolic conditions.⁴,⁵ Follow us for more insights.
0
0
1
@LillyObesityInt
Lilly Obesity International
1 month
We’re committed to advancing #Cardiometabolic care by deepening our understanding of how these interconnected conditions impact people’s lives around the world. Follow us to see how science and purpose come together.
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
As you arrive in Vienna for #EASD2025, Lilly is already there to welcome you. Look out for our message at the airport, a reminder that science, collaboration, and innovation await.
0
0
2
@LillyObesityInt
Lilly Obesity International
1 month
Join us at the Lilly booth during #EASD2025 to explore how we’re advancing #Cardiometabolic care. Dive into engaging scientific resources, interactive exhibits, and connect with our team to learn about the latest innovations driving better #Diabetes care. Don’t miss out!
0
0
1
@LillyObesityInt
Lilly Obesity International
1 month
It is day one of #EASD2025! Join us for a week of science, networking and collaboration in the field of #Diabetes. Visit our booth and join the conversation on #Cardiometabolic care. Follow us to stay updated this week!
0
0
1
@LillyObesityInt
Lilly Obesity International
1 month
Welcome to Vienna for #EASD2025! We are excited to share science and innovation in #Diabetes, #Obesity and #Cardiometabolic care. Come join us at our booth and discover our latest activities. Follow us to stay updated from 15 to 19 September.
0
0
1
@LillyObesityInt
Lilly Obesity International
1 month
Welcome to Vienna! Lilly is proud to welcome the #EASD2025 community to a city rich in charm, history, and scientific innovation. We’re honored to sponsor this year’s congress, and to support the ongoing progress in diabetes care.
0
0
2
@LillyObesityInt
Lilly Obesity International
1 month
As understanding of #Cardiometabolic diseases evolves, modifiable risk factors remain key to prevention & management. Integrating lifestyle changes with pharmacologic therapies gives the best chance to reduce risk prior to onset of irreversible organ damage & improve outcomes.¹,²
0
0
0
@LillyObesityInt
Lilly Obesity International
1 month
During #EASD2025, you may spot our messages raising awareness of Obesity care on Vienna’s U2 and U3 subway lines—encouraging conversations around holistic care. Are you a healthcare professional attending EASD 2025? Follow us for updates.
0
0
1
@LillyObesityInt
Lilly Obesity International
1 month
On the right track with science and progress. Our message on Vienna’s subway doors is a warm welcome to the #EASD2025 community. We look forward to seeing you at the congress!
0
0
1
@LillyObesityInt
Lilly Obesity International
1 month
At #EASD2025, Lilly continues to play an active role in advancing science and improving outcomes in #Diabetes care. Our contribution speaks for itself: through data, research, and collaboration.
0
0
3